Last reviewed · How we verify
Clofibrin (CLOFIBRIC ACID)
Clofibrin (generic name: CLOFIBRIC ACID) is a clofibric acid drug. It is currently FDA-approved.
Clofibrin is a small molecule with the synonyms ACIDE CLOFIBRIQUE, ACIDO CLOFIBRICO, CLOFIBRIC ACID, and CLOFIBRIC ACID.
At a glance
| Generic name | CLOFIBRIC ACID |
|---|---|
| Drug class | clofibric acid |
| Target | Lipoprotein lipase, Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor alpha |
| Modality | Small molecule |
| Therapeutic area | Metabolic |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Pilot Study of Fenofibrate to Prevent Kidney Function Loss in Type 1 Diabetes (PHASE2)
- Adding Evolocumab to Conventional Lipid-lowering Therapy for Hypertriglyceridemia Induced Acute Pancreatitis (NA)
- Evolocumab in Patients With Multivessel Coronary Disease After Acute Myocardial Infarction: A Target Trial Emulation
- Liraglutide Effect in Atrial Fibrillation (PHASE4)
- COAST Study - Cholesterol Optimization After Stroke
- Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia
- Pharmacologic Approaches to Preventing Primary Sclerosing Cholangitis Recurrence After Liver Transplantation (PHASE2)
- Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Clofibrin CI brief — competitive landscape report
- Clofibrin updates RSS · CI watch RSS
Frequently asked questions about Clofibrin
What is Clofibrin?
Clofibrin (CLOFIBRIC ACID) is a clofibric acid drug.
What is the generic name of Clofibrin?
CLOFIBRIC ACID is the generic (nonproprietary) name of Clofibrin.
What drug class is Clofibrin in?
Clofibrin belongs to the clofibric acid class. See all clofibric acid drugs at /class/clofibric-acid.
What development phase is Clofibrin in?
Clofibrin is FDA-approved (marketed).
What does Clofibrin target?
Clofibrin targets Lipoprotein lipase, Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor alpha and is a clofibric acid.
Related
- Drug class: All clofibric acid drugs
- Target: All drugs targeting Lipoprotein lipase, Peroxisome proliferator-activated receptor alpha, Peroxisome proliferator-activated receptor alpha
- Therapeutic area: All drugs in Metabolic
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing